Keywords: Cervical dystonia; Incobotulinumtoxin A; Flexible intervals Background.-Long-term management of cervical dystonia (CD) involves repeated botulinum toxin injections at around 3-month intervals. Many patients and physicians may prefer shorter intervals but it is assumed that these might increase the risk of adverse events (AEs) and neutralizing antibody formation. We analyzed the clinical need and safety of flexible injection intervals with Incobotulinumtoxin A (Xeomin 1 , NT 201), a purified botulinum toxin type A free from accessory (complexing) proteins. Methods.-Post-hoc analysis was carried out using data from a randomized, double-blind, placebo-controlled phase 3 study with a randomized, doubleblind extension period. Subjects with CD (pretreated or botulinum toxin treatment naïve) could receive 6 Incobotulinumtoxin A treatments with fixed doses (120 or 240 U) but flexible intervals (! 6 weeks). Reinjection occurred when subjects and physicians agreed on the need and subjects had a Toronto Western Spasmodic Torticollis Rating Scale Total score of ! 20. Standard safety assessments were performed throughout.
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Results.-Two hundred and fourteen subjects entered the extension period (120 U dose group, n = 103; 240U dose group, n = 111). In total, 821 incoboyulinumtoxin A injections were included in this analysis: 369 (44,9%) given at 6-11 week intervals and 452 (55,1%) at 12-20 weeks intervals. Frequency and severity of AEs were similar, irrespective of injection intervals (< 12 weeks versus ! 12 weeks), with no cumulative effects of repeated treatment. As would be expected in CD, the most frequent AEs were dysphagia, muscle weakness, neck pain, and injection-site pain. Introduction.-The equinus foot deformity is common in hemiparetic patients. Although widely used, the reproducibility of goniometric measurement of ankle dorsiflexion is little studied and variable. The objective was to evaluate the intra/ inter rater-reliability of this measure, and to evaluate a new method of goniometric measurement of ankle dorsiflexion in hemiparetic patients. Methods.-Prospective, monocentric study; all hemiparetic patients due to a recent brain injury, hospitalized during the study period were included. Goniometric measurements of ankle dorsiflexion were performed on both healthy and hemiplegic sides, by four judges, and repeated a week later. Landmarks were either free (corresponding to the evaluators' usual practice) or imposed. The conventional method evaluated the equinus on the hemiparetic side. The S. Index was defined as the difference between the dorsiflexion on the hemiplegic side and on the healthy side. Intra and inter-rater reliabilities were computed for both methods (conventional and S) with an intraclass correlation coefficient (ICC).
Results.-Thirty-four patients were included (88% stroke patients). Intra-rater ICC was good for the classical method (0.72 to 0.78) and ranged from mediocre to moderate for the S. Index (0.43 to 0.70) with imposed landmarks; it ranged from very bad to moderate (0.22 to 0.66) for the S. Index with free landmarks.
Inter-rater ICC was moderate (0.62) for the classical method (free or imposed landmarks) at day 1 and day 7; it was mediocre with imposed landmarks at day 1 and day 7 (0.44 and 0.56) and moderate at day 1 and day 7 (0.52 and 0.56) for the S. index. Discussion.-This study confirmed that the intra and inter-rater reliability of goniometric measurements of equinus were not satisfying, whatever the method. Therefore, the search for a method that has better metrological qualities is necessary. Intra-rater reliability was better with conventional method and free landmarks; however, one coefficient was correct for one judge with the new method, which has to be improved. Inter-rater reliability didn't seem to be better for the S Index. . We aimed to analyze the role of triceps surae spasticity vs cocontraction and tibialis anterior paresis in the hémiparetic gait disorder. Methods.-Nineteen patients with chronic hemiparesis (45 AE 16 years) participated. The spasticity grade and angle (X V1 -X V3 ) of triceps surae (knee extended) and the angle of weakness (X V1 -A) of dorsiflexion were measured using the step-wise assessment of spastic paresis, including the Tardieu scale [2, 3] . Each subject performed a 10-meter barefoot walking test (seated start and arrival) at preferred and maximal speed. Spatial-temporal parameters were quantified: speed, step length and cadence. We explored correlations between spasticity and weakness parameters at the ankle and gait spatial-temporal parameters.
Results.-At preferred speed: speed, 0.69 AE 0.25 m/s; step length, 0.51 AE 0.12 m; cadence, 1.33 AE 0.31step/s. At fast speed: speed, 1.08 AE 0.40 m/s; step length, 0.55 AE 0.15 m; cadence, 1.91 AE 0.39step/s. In the paretic ankle: triceps surae spasticity grade, 2.2 AE 0.8; spasticity angle, 13.7 AE 6.58; dorsiflexion angle of weakness, 13.2 AE 9.38. At preferred speed, the angle of weakness was negatively correlated with speed (r = -0.48, P = 0.039), step length (r = -0.55, P = 0.014), and at fast speed, with speed (r = -0.56, P = 0.012), step length (r = -0.57, P = 0.010) and cadence (r = -0.47, P = 0.040). Conclusions.-In chronic hemiparesis, ambulation (at preferred and fast speed), is correlated at the ankle with the combination of tibialis anterior paresis and triceps surae cocontraction rather than with triceps surae spasticity. References 
